3rd TRT Bellwether Trial to Begin on November 6, 2017
3rd TRT Bellwether Trial to Begin on November 6, 2017
Introduction
The third Testosterone Replacement Therapy bellwether lawsuit is scheduled to go before the jury on November 6 with Auxilium Pharmaceuticals as the defendant for their testosterone based Testim gel. The second Auxilium trial is set for April 9, 2018. Thousands of men have filed lawsuits against Testim gel maker, claiming failure to adequately warn about the potentially life-threatening injuries like heart attacks, stroke, pulmonary embolism, deep vein thrombosis and other blood clots, and death. The company had promoted Testim gel aggressively for the treatment of "Low T" symptoms. The gel works as a reservoir of testosterone that sticks to the skin and delivers the drug through the skin.
Comments
Latest News
First Federal Bellwether Trial Set in Strattice Mesh Case
Categories: Hernia Mesh
Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…
Tepezza Hearing Loss Trial Set for June 2026
Categories: Tepezza
The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.
This decision comes as attorneys…
FDA Moves to Restrict Dangerous 7-OH Opioid Products
Categories: Opioids
In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…